The authors wish to acknowledge the contribution of all participants who have taken part in this study. In addition, the authors wish to thank the following persons: members of the Data Safety Monitoring Committee (Professor David Lalloo, Professor David Hill, Dr Philip Monk) for providing safety oversight of the study; Marcus Morgan and the microbiology laboratory at the Oxford University Hospital NHS foundation Trust; Marianne McClure; Professor Myron M Levine for provision of the S. Typhi Quailes challenge strain; Dr Laura Martin (GSK Vaccines for Global Health) for provision of the S. Paratyphi NVGH308 challenge strain.